skin-cancer

Documents about skin-cancer

• Evaluating a Decision Aid for Sentinel Lymph Node Biopsy in Intermediate-Risk Melanoma#853917ClinicalTrials.gov
• Application of Chinese Herbal Complementary and Alternative Medicine (CAM) to Improve Human Health and to Further Botanical and Horticultural Sciences#863906ClinicalTrials.gov
• BCC-One-Stop-Study#877667ClinicalTrials.gov
• Safety and Efficacy of Oral Midazolam for Perioperative Anxiety Relief of Patients Undergoing Mohs Micrographic Surgery#878506ClinicalTrials.gov
• Study of ONCR-177 Alone and in Combination With PD-1 Blockade in Adult Subjects With Advanced and/or Refractory Cutaneous, Subcutaneous or Metastatic Nodal Solid Tumors or With Liver Metastases of Solid Tumors#1007738ClinicalTrials.gov
• CP-675,206 (CTLA4-Blocking Monoclonal Antibody) Combined With Dendritic Cell Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery#307322ClinicalTrials.gov
• Combination of Decitabine and Temozolomide in the Treatment of Patients With Metastatic Melanoma#860360ClinicalTrials.gov
• Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Combination With Cisplatin, Vinblastine, and Temozolomide in Treating Patients With Recurrent or Metastatic Melanoma#908158ClinicalTrials.gov
• Safety Study of Amphinex Based Photochemical Internalisation (PCI) of Bleomycin in Patients With Cutaneous Cancer#896183ClinicalTrials.gov
• Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors#906675ClinicalTrials.gov
• Bleomycin With or Without Electroporation Therapy in Treating Patients With Stage III or Stage IV Melanoma#993550ClinicalTrials.gov
• Therapeutic Induction of Dermal Remodeling in Veterans to Prevent Actinic Neoplasia Caused by Chronic Environmental Exposure to Ultraviolet Radiation#905531ClinicalTrials.gov
• RNA and Heat Shock Protein Biomarkers in Radiation-induced Fibrosis in Breast Cancer#995003ClinicalTrials.gov
• Identification of Pathways to Mitigate Immune-Related Adverse Events With Cancer Immunotherapy#806141ClinicalTrials.gov
• Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy#140999ClinicalTrials.gov
• Alpha Radiation Emitters Device (DaRT) in Combination With Check Point Inhibitor for the Treatment of Recurrent Unresectable or mHNSCC#307453ClinicalTrials.gov
• Fludarabine Followed by Vaccine Therapy and White Blood Cell Infusions in Treating Patients With Unresectable or Metastatic Melanoma#845108ClinicalTrials.gov
• Generic Drug Structure (Secondary/Tertiary Amino Groups) within the Polypharmacy as Main Risk Factors for Skin Related (Nitroso) Photocarcinogenicity but also for a Solid Human Cancer: Investigative Report with Focus on Cutaneous Melanoma and Prostate CA#384668HAL (France)
• Complications and Recurrences After Mohs Micrographic Surgery and Slow Mohs#803968ClinicalTrials.gov
• Rituxan and Abraxane for the Treatment of Patients With Inoperable Stage III and IV Malignant Melanoma#883372ClinicalTrials.gov
• Study of the Selective PI3K-Beta Inhibitor GSK2636771 in Combination With Pembrolizumab in Patients With Metastatic Melanoma and PTEN Loss#836008ClinicalTrials.gov
• Dendritic Cell Vaccination During Lymphoid Reconstruction#910910ClinicalTrials.gov
• Knowledge and Risk Perception Regarding Skin Cancer in Immunosuppressed Patients: A Systematic Review and Meta-Analysis / Luisa Leonie Brokmeier, Sophia Haas, Laura Ilic, Wolfgang Uter, Markus Vincent Heppt, Olaf Gefeller, Isabelle Kaiser ; Herausgeber: Alina Cernasev#675504Deutsche Nationalbibliothek
• 131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients#859994ClinicalTrials.gov
• Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers#18594ClinicalTrials.gov
• Answering Questions About Vitamin D Supplementation and Sun Exposure in Patients Who Have Undergone Surgery for Stage IB, Stage II, or Stage IIIA Melanoma#914816ClinicalTrials.gov
• Secondary / Tertiary Amines in the Generic Polymedication as Milestone for Drug / Food – Related Nitroso Formation and Subsequent Photocarcinogenicity / Skin Cancer Development in Humans: Advancement / Rotation Flaps as Treatment Choice#427386HAL (France)
• Vaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Nivolumab or Ipilimumab With Nivolumab For Patients With Resected Stages IIIC/ IV Melanoma#904279ClinicalTrials.gov
• FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER)#882957ClinicalTrials.gov
• Investigation on the efficacy of luliconazole-loaded nanostructured lipid carriers for the treatment of skin and nail fungal infection: <i>In-vitro, in-vivo,</i> and <i>ex-vivo</i> characterization#609489Figshare
• Evaluation of Efficacy and Safety of Cemiplimab as First Line Treatment for Advanced Basal Cell Carcinoma (BCC) Patients#813639ClinicalTrials.gov
• PHOENIX-ECP- Extracorporeal Photopheresis for Immune-related Colitis and/or Hepatitis in Advanced Melanoma With Inadequate Response to Steroid Exposure#864722ClinicalTrials.gov
• A Phase I, Exploratory, Intra-patient Dose Escalation Study to Investigate the Preliminary Safety, Pharmacokinetics, and Anti-tumor Activity of Pasireotide (SOM230) s.c.Followed by Pasireotide LAR in Patients With Metastaticmelanoma or Metastatic Merkel Cell Carcinoma#867320ClinicalTrials.gov
• Studying the Workflow of the American College of Surgeons Geriatric Surgery Program to Improve Clinical Outcomes in Older Adults Undergoing Surgery at the James Cancer Hospital#917051ClinicalTrials.gov
• REACH: Study to Determine the Aetiology of Chlormethine Gel Induced-skin Drug Reaction in Early Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL)#827024ClinicalTrials.gov
• Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy#857766ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma#866018ClinicalTrials.gov
• Task Shifting and Skin Punch for the Histologic Diagnosis of Kaposi's Sarcoma in Sub-Saharan Africa: A Public Health Solution to a Public Health Problem#683983eScholarship
• Intratumoral Cavrotolimod Combined With Pembrolizumab or Cemiplimab in Patients With Merkel Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, or Other Advanced Solid Tumors#897089ClinicalTrials.gov
• Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic#844615ClinicalTrials.gov
• Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer#871278ClinicalTrials.gov